20.92MMarket Cap0.80P/E (TTM)
3.1499High3.0800Low3.62KVolume3.1150Open3.0501Pre Close11.33KTurnover0.07%Turnover RatioLossP/E (Static)6.66MShares6.909952wk High0.41P/B15.49MFloat Cap2.729352wk Low--Dividend TTM4.93MShs Float12210.9816Historical High--Div YieldTTM2.29%Amplitude2.7293Historical Low3.1270Avg Price1Lot Size
MEI Pharma Stock Forum
NEWS
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
MEI Pharma, Inc. reports positive results from the ongoing Phase 1b study of ME-344 in combination with bevacizumab for relapsed metastatic colorectal cancer. 25% of patients had no disease progression at Week 16, exceeding the threshold to add more patients. The combination was well-tolerated, leading to the...
$Gossamer Bio (GOSS.US)$ $Starry Group (STRY.US)$ $Helbiz (HLBZ.US)$ $MEI Pharma (MEIP.US)$ $Digital Brands Group (DBGI.US)$ $Cosmos Health (COSM.US)$ $COMSovereign (COMS.US)$ $Mirati Therapeutics (MRTX.US)$ $United Parcel Service (UPS.US)$ $Sumo Logic (SUMO.US)$
wherr is thr link for earnings
Tomorrow to the 🚀🌕
https://www.etfdailynews.com/2022/05/02/mei-pharma-inc-nasdaqmeip-sees-significant-increase-in-short-interest/
Finally
No comment yet